SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern
SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern. // Diabetes Research and Clinical Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0168822726005590?dgcid=rss_sd_all
SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern. Diabetes Research and Clinical Practice. https://www.sciencedirect.com/science/article/pii/S0168822726005590?dgcid=rss_sd_all
“SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern.” Diabetes Research and Clinical Practice.
@article{article43114,
title = {SGLT2 inhibitor-induced genitourinary infections and the consequent antimicrobial-antidiabetic drug interactions: A narrative review of clinical and pharmacovigilance concern},
journal = {Diabetes Research and Clinical Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0168822726005590?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...